TL
Telix Pharmaceuticals Limited
TLPPF · OTC
$12.24 +11.17% (+$1.23)
1M +6.43%
Market Cap $5.82B
P/E Ratio -
Div. Yield -
ROE 1.74%
Bulios Fair Price
$15.74
28.6% upside
Current Price
$12.24
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TLPPF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
8 /100
Expensive EV/EBITDA 77.43x
P/B 9.34x
P/S 4.67x
Growth
100 /100
Growing Rev. growth 98.18%
Book val. growth 98.17%
EPS growth N/A
Profitability
23 /100
Weak Gross margin 53.11%
FCF margin 6.87%
Net margin 0.89%
Quality
13 /100
Poor ROIC 2.56%
Asset turnover 0.70x
ROE 1.74%
Debt
25 /100
High Debt/Equity 1.26x
Net debt/EBITDA 6.93x
Current ratio 1.43x
Stability
26 /100
Unstable Beta 0.60x
Profitable years 0
Rev. volatility 90.33%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TLPPF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christian Behrenbruch
Employees
1,184
Headquarters
North Melbourne
Upcoming events
19 FEB
Earnings
Upcoming earnings report